Stock Details
NVO is Novo Nordisk A/S's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 140.05$. Average daily volumn in 3 months 1.44M. Market cap 327.91B

Stock symbol : NVO. Exchange : NYSE. Currency : USD
Lastest price : 145.72$. Total volume : 323.35k. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

Novo Nordisk A/S (NVO)
Last Price

Previous Close143.59
Day Range144.79-145.99
Bid145.80 x 1k
Ask145.82 x 800
Average Volume1.44M
Market Cap327.91B
52 Week Range95.02-145.99
Trailing P/E41.99
Foward P/E28.24
Dividend (Yield %)1.27%
Ex-Dividend Date2023-03-24

Financial Details

According to Novo Nordisk A/S's financial reports the company's revenue in 2022 were 176.95B an increase( +25.71%) over the years 2021 revenue that were of 140.8B. In 2022 the company's total earnings were 55.52B while total earnings in 2021 were 47.76B( +17.02%).

Loading ...


Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormon... e replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Market Cap:
Total Assets:
Total Cash:

News about "Novo Nordisk A/S"


Novo Nordisk A/S - share repurchase programme

Source from : YAHOO!Finance - 1 days ago

On 1 February 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the ...See details»

Should You Invest in Novo Nordisk A/S (NVO)?

Source from : Insider Monkey - 14 days ago

In addition, please check the fundโ€™s top five holdings to know its best picks in 2022. ClearBridge Sustainability Leaders Strategy highlighted stocks like Novo Nordisk A/S (NYSE:NVO) in the Q4 ...See details»

Novo Nordisk A/S (NVO) Stock: A Closer Look at the Analyst Ratings

Source from : newsheater - 6 days ago

Novo Nordisk A/S (NYSE: NVO) has a price-to-earnings ratio of 41.33x that is above its average ratio. Additionally, the 36-month beta value for NVO is 0.47. There are mixed opinions on the stock, with ...See details»

Novo Nordisk A/S Series B

Source from : Wall Street Journal - 7 days ago

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...See details»

Novo Nordisk A/S (NVO) Outperformed and Reported 16% Sales Growth in Q4

Source from : Insider Monkey - 8 days ago

In addition, please check the fundโ€™s top five holdings to know its best picks in 2022. Artisan Global Opportunities Fund highlighted stocks like Novo Nordisk A/S (NYSE:NVO) in the Q4 2022 ...See details»

Novo Nordisk A/S Class B (NOVOb)

Source from : Investing - 3 days ago

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...See details»

Novo Nordisk plans to cut insulin prices up to 75%, following Eli Lilly

Source from : Orange County Register - 7 days ago

Novo Nordisk A/S, one of the worldโ€™s biggest makers of insulin, said it would cut US prices for several of its products by up to 75%, following similar actions by rival Eli Lilly & Co. Novo will ...See details»

Novo Nordisk latest pharmaceutical company to cut price of insulin

Source from : Yahoo News - 2 days ago

Two weeks after Eli Lillyโ€™s move to cap insulin prices at $35, another second company has entered the chat. On Tuesday, Novo Nordisk announced that effective Jan.1, 2024, it will be lowering U.S. list ...See details»


Novo Nordisk becomes second company to announce cuts to US insulin prices

Source from : YAHOO!News - 7 days ago

Danish pharmaceutical company Novo Nordisk announced on Tuesday it would be lowering the prices of some of its insulin products in the U.S. by up to 75 percent, becoming the second company to take ...See details»

Novo Nordisk Follows Eli Lillyโ€™s Lead, Lowering Insulin Prices up to 75%

Source from : MedCity News - 7 days ago

Novo Nordisk is slashing prices of several insulin products by up to 75% amid growing political scrutiny on the prices of these older but still expensive diabetes medicines. The announcement ...See details»

Novo Nordisk A/S: Novo Nordisk announces changes in Executive Management

Source from : Finanznachrichten - 14 days ago

Novo Nordisk's B shares are listed on Nasdaq Copenhagen,Facebook, Twitter, LinkedIn andYouTube. Contact for further information Company announcement No 17 / 2023 ...See details»

Novo Nordisk (NVO) Stock Sinks As Market Gains: What You Should Know

Source from : Nasdaq - 4 days ago

Novo Nordisk (NVO) closed the most recent trading day at $138.89, moving -1.48% from the previous trading session. This change lagged the S&P 500's 1.76% gain on the day. Meanwhile, the Dow gained ...See details»

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Source from : Yahoo Finance - 1 month ago

Bagsvรฆrd, Denmark, 14 February 2023 โ€” This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the companyโ€™s board members, executives and their associated ...See details»

Novo Nordisk A/S - share repurchase programme

Source from : Yahoo Finance - 8 days ago

Bagsvรฆrd, Denmark, 13 March 2023 โ€“ On 1 February 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and ...See details»